HSICNasdaqWholesale-Medical, Dental & Hospital Equipment & SuppliesUS GAAP · USD

Henry Schein, Inc

Henry Schein is a health care solutions company that distributes products and provides services primarily to office-based dental and medical practitioners, as well as alternate sites of care. It combines broad consumables and equipment distribution with specialty manufacturing and practice software, positioning itself as a single-source supplier for clinical and practice-management needs.

Revenue13.2bn USD
+4.0 %y/y
Operating profit (EBIT)653m USD
+5.2 %y/y
EBIT margin5.0%
+0.1 ppy/y
Net income398m USD
+2.1 %y/y
Free cash flow712m USD
−16.0 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

051015bn USD2020: 10.1 bn USD2020: EBIT 0.54 bn USD20202021: 12.4 bn USD2021: EBIT 0.85 bn USD20212022: 12.6 bn USD2022: EBIT 0.75 bn USD20222023: 12.3 bn USD2023: EBIT 0.62 bn USD20232024: 12.7 bn USD2024: EBIT 0.62 bn USD20242025: 13.2 bn USD2025: EBIT 0.65 bn USD202513.20.65
RevenueOperating profit (EBIT)

Business

Share of revenue
Global Distribution and Value-Added Services72 %

Distribution of branded and corporate-brand consumables, equipment, pharmaceuticals, and related services for dental and medical practices.

Global Specialty Products18 %

Manufactured and specialty dental and health care products including implants, biomaterials, endodontic, orthodontic, and orthopedic offerings.

Global Technology8 %

Practice management software, cloud-based tools, revenue cycle management, and patient relationship solutions.

Home Health and Alternate Care2 %

Medical supplies and devices delivered directly to patients and alternate care settings through the distribution network.

Customers

The company sells to a wide base of office-based health care providers, including dental practices, physician practices, laboratories, ambulatory surgery centers, and alternate care clinics. It also serves larger organized buyers such as DSOs, GPOs, HMOs, IDNs, government, and institutional health care customers that value scale, pricing, and practice-management support.

Dental practices

Buy consumables, equipment, implants, biomaterials, and software to run chairside operations and improve practice efficiency.

Physician practices and ambulatory surgery centers

Buy medical supplies, pharmaceuticals, equipment, and service support for office-based and outpatient care.

DSOs, GPOs, and managed care organizations

Buy at scale for multiple locations and value competitive pricing, centralized ordering, and management information support.

Labs, institutional clinics, and alternate care providers

Buy recurring supplies and services for specialized care settings and non-hospital delivery models.

Home health patients and providers

Buy direct-to-patient medical supplies and devices for chronic care and home-based treatment adherence.

Strategy

The company is focused on being a single-source supplier by combining broad distribution, specialty products, and software-enabled services. Its strategy emphasizes customer retention through e-commerce, field sales, practice services, and acquisitions that add customers, geographies, and new technologies.

Broaden the integrated product-and-service platformMedium term

A wider offering increases customer stickiness and supports cross-selling across dental and medical accounts.

Grow cloud-based and recurring technology revenueMedium term

Software and revenue cycle management carry higher margins and deepen workflow integration with customers.

Use acquisitions to expand footprint and product accessMedium term

Acquisitions can add customers, sales teams, and new technologies faster than organic growth alone.

Improve operating efficiency and fulfillment reliabilityShort term

Distribution economics depend on inventory availability, logistics, and service quality.

Geography

2025

Henry Schein is headquartered in Melville, New York and operates in 34 countries and territories, with a workforce split roughly 48% in the U.S. and 52% outside the U.S. Its distribution and manufacturing footprint spans 38 distribution centers and 17 manufacturing facilities, supporting local fulfillment and service delivery across North America, Europe, and other international markets.

United States69 %
Other countries (US filing)31 %

Share of the revenue the company reports by geography.

Risks

The business depends on third-party suppliers for a large share of distributed products and raw materials, so supply disruption or supplier concentration can affect availability, rebates, and margins. It also faces intense competition from distributors, manufacturers selling direct, and online commerce, while cybersecurity and data privacy remain material operational risks after the 2023 incident.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Cybersecurity and data breach exposure1Third-party supplier concentration and supply disruption2Manufacturers selling direct to end customers3Competitive pricing pressure4Acquisition and integration execution5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Cybersecurity and data breach exposureImpact: HighLikelihood: High

    The company processes sensitive health, billing, and patient data across global systems.

    Exposure: Residual impact from the October 2023 cybersecurity incident

  2. Third-party supplier concentration and supply disruptionImpact: HighLikelihood: Medium

    The company sources a significant volume of products from external suppliers without long-term contracts.

    Exposure: Top 10 Global Distribution and Value-Added Services suppliers accounted for about 24% of purchases

  3. Manufacturers selling direct to end customersImpact: HighLikelihood: Medium

    Direct sales can reduce the role of distributors and compress margins in dental and medical categories.

    Exposure: Particularly relevant in dental specialty products and some medical categories

  4. Competitive pricing pressureImpact: MediumLikelihood: High

    Customers can source many products from multiple distributors and online channels.

    Exposure: Broad product categories and e-commerce channels

  5. Acquisition and integration executionImpact: MediumLikelihood: Medium

    Growth strategy relies partly on acquisitions that must be integrated into sales, systems, and operations.

    ExposureCustomerTechnologyGeographic expansion deals

Accounting

Judgemental items
Seasonality and working capital

Sales are typically stronger in the second half and inventory buy-ins raise receivables and inventory needs.

Impact: Quarterly cash flow and balance-sheet comparability

Goodwill and intangible asset impairment

Acquisitions and portfolio changes require periodic impairment testing using cash flow and royalty assumptions.

Impact: Potential non-cash charges to earnings

Redeemable noncontrolling interests

Some minority holders can require repurchase at fair value, creating a liability-like balance-sheet item.

Impact: Can change equity and reported obligations

Restructuring and exit costs

Restructuring initiatives can include severance, lease, and asset-related charges.

Impact: Affects operating expense trends and comparability

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Henry Schein, Inc (HSIC) Revenue, Earnings & Financials 2025 – Clarifo